Advancing Global Health Equity & Harmonization
Join us for the first annual Cure4Cancer conference focused on advancing global health equity and harmonization.
Source: asiasociety.org
Qing Zhou News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Qing Zhou. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Qing Zhou Today - Breaking & Trending Today
ASCO 2023: Solid Tumors
Coverage of clinical trial results presented across a range of solid tumor cancers, including breast, ovarian, colorectal, and non-small cell lung cancer, among other types; as well as important findings in genomic testing.
Source: ajmc.com
I-Mab Announces Encouraging Phase 1b/2 Study Results of Patients with Advanced NSCLC Receiving Uliledlimab and Toripalimab Combination Therapy at ASCO 2023
- Uliledlimab is a differentiated monoclonal antibody designed to target CD73 and promote stronger activation of patients' immune system against cancer cells....
Source: prnewswire.com
I-Mab Announces Poster Presentation of Proprietary CD73 Antibody Uliledlimab at ASCO 2023
/PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization...
Source: prnewswire.com
IBI351 Demonstrates Early Antitumor Activity and Tolerability in KRAS G12C+ Advanced NSCLC
The recommended phase 2 dose of IBI351 monotherapy had favorable safety and encouraging efficacy signals when administered to patients with advanced KRAS G12C–mutated non–small cell lung cancer, according to updated data from a phase 1 dose-escalation study.
Source: onclive.com